BAKER BROS. ADVISORS LP Q1 2023 Filing

Filed May 15, 2023

Portfolio Value

$18.4B

Holdings

105

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (105 positions)

#StockSharesValue% PortfolioType
101
—Genetron Holdings Limited
455,306$478.0M2.60%
102
FHTXFoghorn Therapeutics Inc.
45,027$279.0M1.52%
103
—Vincerx Pharma, Inc.
241,379$251.0M1.37%
104
SRZNWSurrozen, Inc.
833,333$83.0M0.45%
105
—Bellicum Pharmaceuticals, Inc.
249,123$82.0M0.45%
PreviousPage 2 of 2